⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylsulfanylmethane SCHEMBL7985077 | 0.72 | — | — | |
| Methylsulfanylmethane SCHEMBL5440614 | 0.71 | — | — | |
| Methylsulfanylmethane SCHEMBL1330443 | 0.71 | — | — | |
| Methylsulfanylmethane SCHEMBL1618 | 0.71 | — | — | |
| SCHEMBL4924237 | 0.71 | — | — | |
| Methylsulfanylmethane SCHEMBL58269 | 0.67 | — | — | |
| Methylsulfanylmethane SCHEMBL3283496 | 0.67 | — | — | |
| Methylsulfanylmethane SCHEMBL9003352 | 0.67 | — | — | |
| Methylsulfanylmethane SCHEMBL23701635 | 0.63 | — | — | |
| Methylsulfanylmethane SCHEMBL7706316 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043636-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-07-23 | — | — | US | disclosed |
| US-20240002409-A1 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-04 | — | — | US | disclosed |
| US-11760765-B2 | Method for producing triarylorganoborates | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2023-09-19 | — | — | US | disclosed |
| CN-110325521-B | Process for preparing triarylorganoborates | 科思创德国股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-110177797-B | Method for producing triaryl organic borate salts | 科思创德国股份有限公司 | 2022-09-23 | — | — | CN | disclosed |